These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30566586)

  • 1. RGD inhibition of itgb1 ameliorates laminin-α2-deficient zebrafish fibre pathology.
    Wood AJ; Cohen N; Joshi V; Li M; Costin A; Hersey L; McKaige EA; Manneken JD; Sonntag C; Miles LB; Siegel A; Currie PD
    Hum Mol Genet; 2019 May; 28(9):1403-1413. PubMed ID: 30566586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle.
    Cohn RD; Mayer U; Saher G; Herrmann R; van der Flier A; Sonnenberg A; Sorokin L; Voit T
    J Neurol Sci; 1999 Mar; 163(2):140-52. PubMed ID: 10371075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linker proteins restore basement membrane and correct
    Reinhard JR; Lin S; McKee KK; Meinen S; Crosson SC; Sury M; Hobbs S; Maier G; Yurchenco PD; Rüegg MA
    Sci Transl Med; 2017 Jun; 9(396):. PubMed ID: 28659438
    [No Abstract]   [Full Text] [Related]  

  • 4. The zebrafish candyfloss mutant implicates extracellular matrix adhesion failure in laminin alpha2-deficient congenital muscular dystrophy.
    Hall TE; Bryson-Richardson RJ; Berger S; Jacoby AS; Cole NJ; Hollway GE; Berger J; Currie PD
    Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7092-7. PubMed ID: 17438294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laminin-α2 Chain-Deficient Congenital Muscular Dystrophy: Pathophysiology and Development of Treatment.
    Durbeej M
    Curr Top Membr; 2015; 76():31-60. PubMed ID: 26610911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A splice site mutation in laminin-α2 results in a severe muscular dystrophy and growth abnormalities in zebrafish.
    Gupta VA; Kawahara G; Myers JA; Chen AT; Hall TE; Manzini MC; Currie PD; Zhou Y; Zon LI; Kunkel LM; Beggs AH
    PLoS One; 2012; 7(8):e43794. PubMed ID: 22952766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy.
    Rooney JE; Knapp JR; Hodges BL; Wuebbles RD; Burkin DJ
    Am J Pathol; 2012 Apr; 180(4):1593-602. PubMed ID: 22322301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epistatic dissection of laminin-receptor interactions in dystrophic zebrafish muscle.
    Sztal TE; Sonntag C; Hall TE; Currie PD
    Hum Mol Genet; 2012 Nov; 21(21):4718-31. PubMed ID: 22859503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant Caspase Activation in Laminin-α2-Deficient Human Myogenic Cells is Mediated by p53 and Sirtuin Activity.
    Yoon S; Beermann ML; Yu B; Shao D; Bachschmid M; Miller JB
    J Neuromuscul Dis; 2018; 5(1):59-73. PubMed ID: 29278895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ku70 regulates Bax-mediated pathogenesis in laminin-alpha2-deficient human muscle cells and mouse models of congenital muscular dystrophy.
    Vishnudas VK; Miller JB
    Hum Mol Genet; 2009 Dec; 18(23):4467-77. PubMed ID: 19692349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laminin-deficient muscular dystrophy: Molecular pathogenesis and structural repair strategies.
    Yurchenco PD; McKee KK; Reinhard JR; Rüegg MA
    Matrix Biol; 2018 Oct; 71-72():174-187. PubMed ID: 29191403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β1D chain increases α7β1 integrin and laminin and protects against sarcolemmal damage in mdx mice.
    Liu J; Milner DJ; Boppart MD; Ross RS; Kaufman SJ
    Hum Mol Genet; 2012 Apr; 21(7):1592-603. PubMed ID: 22180459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laminin α1 reduces muscular dystrophy in dy
    Gawlik KI; Harandi VM; Cheong RY; Petersén Å; Durbeej M
    Matrix Biol; 2018 Sep; 70():36-49. PubMed ID: 29544677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent pro-inflammatory and pro-fibrotic molecules, osteopontin and galectin-3, are not major disease modulators of laminin α2 chain-deficient muscular dystrophy.
    Gawlik KI; Holmberg J; Svensson M; Einerborg M; Oliveira BM; Deierborg T; Durbeej M
    Sci Rep; 2017 Mar; 7():44059. PubMed ID: 28281577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy.
    Vachon PH; Xu H; Liu L; Loechel F; Hayashi Y; Arahata K; Reed JC; Wewer UM; Engvall E
    J Clin Invest; 1997 Oct; 100(7):1870-81. PubMed ID: 9312189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laminin alpha1 chain mediated reduction of laminin alpha2 chain deficient muscular dystrophy involves integrin alpha7beta1 and dystroglycan.
    Gawlik KI; Mayer U; Blomberg K; Sonnenberg A; Ekblom P; Durbeej M
    FEBS Lett; 2006 Mar; 580(7):1759-65. PubMed ID: 16504180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral nerve pathology, including aberrant Schwann cell differentiation, is ameliorated by doxycycline in a laminin-α2-deficient mouse model of congenital muscular dystrophy.
    Homma S; Beermann ML; Miller JB
    Hum Mol Genet; 2011 Jul; 20(13):2662-72. PubMed ID: 21505075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysing regenerative potential in zebrafish models of congenital muscular dystrophy.
    Wood AJ; Currie PD
    Int J Biochem Cell Biol; 2014 Nov; 56():30-7. PubMed ID: 25449259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linker molecules between laminins and dystroglycan ameliorate laminin-alpha2-deficient muscular dystrophy at all disease stages.
    Meinen S; Barzaghi P; Lin S; Lochmüller H; Ruegg MA
    J Cell Biol; 2007 Mar; 176(7):979-93. PubMed ID: 17389231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy is increased in laminin α2 chain-deficient muscle and its inhibition improves muscle morphology in a mouse model of MDC1A.
    Carmignac V; Svensson M; Körner Z; Elowsson L; Matsumura C; Gawlik KI; Allamand V; Durbeej M
    Hum Mol Genet; 2011 Dec; 20(24):4891-902. PubMed ID: 21920942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.